How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data

Jozsef Batorfi, Gyorgy Vegh, Janos Szepesi, Ivan Szigetvari, Jozsef Doszpod, V. Fülöp

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: We analyzed human chorionic gonadotropin (hCG) follow-up data of patients with molar pregnancy. Women often do not complete recommended post-disease screening. Our purpose was to determine if continuing follow up of uncomplicated molar cases beyond attaining undetectable hCG levels is necessary for detecting relapse of gestational trophoblastic disease. Study design: One hundred fifty patients treated at Hungarian National Health Center were analyzed. Those who developed persistent disease before hCG had become undetectable were excluded from further analysis (n=24; 16%). Results: Among 126 uncomplicated cases, 72 patients (57%) completed follow up, and 54 (43%) discontinued their protocol before it had been completed. Of 120 patients who achieved at least one undetectable hCG level, none had any evidence of relapse. Conclusion: In uncomplicated hydatidiform mole, our analysis indicates that once undetectable serum hCG levels are attained, relapse is unlikely. Although further monthly checks are advisable, the likelihood of recurrence appears very low.

Original languageEnglish
Pages (from-to)95-97
Number of pages3
JournalEuropean Journal of Obstetrics Gynecology and Reproductive Biology
Volume112
Issue number1
DOIs
Publication statusPublished - Jan 15 2004

Fingerprint

Hydatidiform Mole
Chorionic Gonadotropin
Recurrence
Serum
Gestational Trophoblastic Disease
Health

Keywords

  • Complete and partial hydatidiform mole
  • Follow up
  • Gestational trophoblastic disease
  • hCG
  • Human chorionic gonadotropin

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data. / Batorfi, Jozsef; Vegh, Gyorgy; Szepesi, Janos; Szigetvari, Ivan; Doszpod, Jozsef; Fülöp, V.

In: European Journal of Obstetrics Gynecology and Reproductive Biology, Vol. 112, No. 1, 15.01.2004, p. 95-97.

Research output: Contribution to journalArticle

Batorfi, Jozsef ; Vegh, Gyorgy ; Szepesi, Janos ; Szigetvari, Ivan ; Doszpod, Jozsef ; Fülöp, V. / How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data. In: European Journal of Obstetrics Gynecology and Reproductive Biology. 2004 ; Vol. 112, No. 1. pp. 95-97.
@article{02b2fc6b0de0473b95f57132579f0285,
title = "How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data",
abstract = "Objective: We analyzed human chorionic gonadotropin (hCG) follow-up data of patients with molar pregnancy. Women often do not complete recommended post-disease screening. Our purpose was to determine if continuing follow up of uncomplicated molar cases beyond attaining undetectable hCG levels is necessary for detecting relapse of gestational trophoblastic disease. Study design: One hundred fifty patients treated at Hungarian National Health Center were analyzed. Those who developed persistent disease before hCG had become undetectable were excluded from further analysis (n=24; 16{\%}). Results: Among 126 uncomplicated cases, 72 patients (57{\%}) completed follow up, and 54 (43{\%}) discontinued their protocol before it had been completed. Of 120 patients who achieved at least one undetectable hCG level, none had any evidence of relapse. Conclusion: In uncomplicated hydatidiform mole, our analysis indicates that once undetectable serum hCG levels are attained, relapse is unlikely. Although further monthly checks are advisable, the likelihood of recurrence appears very low.",
keywords = "Complete and partial hydatidiform mole, Follow up, Gestational trophoblastic disease, hCG, Human chorionic gonadotropin",
author = "Jozsef Batorfi and Gyorgy Vegh and Janos Szepesi and Ivan Szigetvari and Jozsef Doszpod and V. F{\"u}l{\"o}p",
year = "2004",
month = "1",
day = "15",
doi = "10.1016/S0301-2115(03)00274-4",
language = "English",
volume = "112",
pages = "95--97",
journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data

AU - Batorfi, Jozsef

AU - Vegh, Gyorgy

AU - Szepesi, Janos

AU - Szigetvari, Ivan

AU - Doszpod, Jozsef

AU - Fülöp, V.

PY - 2004/1/15

Y1 - 2004/1/15

N2 - Objective: We analyzed human chorionic gonadotropin (hCG) follow-up data of patients with molar pregnancy. Women often do not complete recommended post-disease screening. Our purpose was to determine if continuing follow up of uncomplicated molar cases beyond attaining undetectable hCG levels is necessary for detecting relapse of gestational trophoblastic disease. Study design: One hundred fifty patients treated at Hungarian National Health Center were analyzed. Those who developed persistent disease before hCG had become undetectable were excluded from further analysis (n=24; 16%). Results: Among 126 uncomplicated cases, 72 patients (57%) completed follow up, and 54 (43%) discontinued their protocol before it had been completed. Of 120 patients who achieved at least one undetectable hCG level, none had any evidence of relapse. Conclusion: In uncomplicated hydatidiform mole, our analysis indicates that once undetectable serum hCG levels are attained, relapse is unlikely. Although further monthly checks are advisable, the likelihood of recurrence appears very low.

AB - Objective: We analyzed human chorionic gonadotropin (hCG) follow-up data of patients with molar pregnancy. Women often do not complete recommended post-disease screening. Our purpose was to determine if continuing follow up of uncomplicated molar cases beyond attaining undetectable hCG levels is necessary for detecting relapse of gestational trophoblastic disease. Study design: One hundred fifty patients treated at Hungarian National Health Center were analyzed. Those who developed persistent disease before hCG had become undetectable were excluded from further analysis (n=24; 16%). Results: Among 126 uncomplicated cases, 72 patients (57%) completed follow up, and 54 (43%) discontinued their protocol before it had been completed. Of 120 patients who achieved at least one undetectable hCG level, none had any evidence of relapse. Conclusion: In uncomplicated hydatidiform mole, our analysis indicates that once undetectable serum hCG levels are attained, relapse is unlikely. Although further monthly checks are advisable, the likelihood of recurrence appears very low.

KW - Complete and partial hydatidiform mole

KW - Follow up

KW - Gestational trophoblastic disease

KW - hCG

KW - Human chorionic gonadotropin

UR - http://www.scopus.com/inward/record.url?scp=0346995419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346995419&partnerID=8YFLogxK

U2 - 10.1016/S0301-2115(03)00274-4

DO - 10.1016/S0301-2115(03)00274-4

M3 - Article

C2 - 14687748

AN - SCOPUS:0346995419

VL - 112

SP - 95

EP - 97

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology

SN - 0028-2243

IS - 1

ER -